Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD)
Rare Disease
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| govorestat | Applied Therapeutics, Inc. (APLT) |
Frequently asked questions
How many drugs are in development for Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD)?
BioSniper tracks 1 drug in development for Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD) across 1 company.
How many clinical trials target Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD)?
There are 1 clinical trial targeting Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD) tracked by BioSniper.
Deep-dive into Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis